purpos
subacut
studi
evalu
method
canin
circul
immunoglobulin
igm
igg
ige
select
band
tlymphocyt
popul
pant
panb
immunotox
test
use
organ
system
concord
approach
challeng
substanc
immunoglobulin
test
repeat
immun
sixway
distemp
vaccin
dhlapp
challeng
substanc
leukocyt
subpopul
treatment
cyclophosphamid
immunoglobulin
measur
made
captur
enzymelink
immunosorb
assay
elisa
leukocyt
immunophenotyp
fluorescein
isothiocyanatephycoerythrin
conjug
flow
cytometri
batteri
paramet
would
use
typic
regulatori
studi
taken
aid
interpret
data
gener
method
bodi
weight
food
consumpt
clinic
observ
complet
clinic
chemistri
urinalysi
measur
taken
gross
patholog
micropatholog
sternal
bone
marrow
spleen
mesenter
retropharyng
lymph
node
thymu
liver
kidney
complet
elisa
method
demonstr
accept
intraassay
reproduc
igm
igg
ige
valu
good
agreement
report
radial
immunodiffus
immunolog
challeng
demonstr
biolog
trend
increas
igm
preced
increas
igg
discern
trend
ige
respons
abnorm
lymphocyt
subpopul
principl
flow
cytometri
find
relat
cyclophosphamid
rel
percent
b
cell
decreas
dramat
progress
compound
administr
statist
decreas
male
day
compar
day
rel
percent
contribut
increas
ratio
remain
rel
unchang
total
white
blood
cell
decreas
progress
increas
rel
percent
male
statist
signific
accord
twosampl
ttest
day
compar
pretreat
day
rel
percent
increas
absolut
number
dramat
decreas
conclud
organ
system
approach
assess
immun
system
incorpor
humor
antibodi
enumer
lymphocyt
popul
patholog
evalu
lymphoreticular
organ
assist
interpret
advers
toxicolog
respons
elisa
method
measur
ig
detect
expect
level
igg
igm
ige
due
repeat
vaccin
cyclophosphamid
treatment
flow
cytometri
method
accept
wwwelseviercomlocatetoxlet
rd
jone
et
al
toxicolog
letter
measur
select
canin
lymphocyt
popul
detect
expect
decreas
b
cell
due
cyclophosphamid
treatment
method
may
ad
test
batteri
assess
immunotox
canin
regulatori
studi
dog
import
immunolog
model
mechan
work
diseas
atopi
rheumatoid
arthriti
autoimmun
hemolyt
anemia
autoimmun
thrombocytopenia
autoimmun
thyroid
autoimmun
dermal
condit
system
lupu
erythematosi
pedersen
pool
imunodefici
dwarfism
relev
model
elucid
endocrin
role
thymu
relationship
neuroendocrin
immun
system
prepubert
dog
roth
et
al
moreov
predict
pharmaceut
agent
human
toxic
preclin
anim
speci
almost
dog
primat
studi
toxic
identifi
rat
studi
alon
olson
et
al
therefor
scientif
medic
rational
use
dog
altern
immunolog
model
rodent
speci
extend
beyond
nonrod
altern
regulatori
studi
use
albino
rodent
model
often
justifi
basi
reduc
mainten
cost
eas
reagent
develop
recent
progress
transgen
model
burn
et
al
seem
conduc
specif
hypothesi
test
dog
nonspecif
serum
immunoglobulin
level
consid
one
common
assess
immunocompet
clinic
diseas
german
et
al
nonspecif
immunoglobulin
chang
success
use
human
occup
medicin
investig
possibl
immunotox
potenti
pesticid
mixtur
air
pollut
screen
possibl
atop
immunoglobulin
ig
emedi
diseas
stillerwinkl
et
al
specif
antigen
exposur
known
inject
expos
test
subject
enhanc
detect
immunolog
respons
exampl
measur
antigen
specif
respons
dog
vaccin
barthold
et
al
diagnosi
atop
condit
parasit
hammerberg
et
al
autoimmun
diseas
jone
et
al
immunolog
challeng
inject
sheep
red
blood
cell
captur
enzymelink
immunosorb
assay
elisa
method
chosen
advantag
enhanc
immunolog
sensit
accuraci
compar
exist
radial
immunodiffus
rid
method
ginel
et
al
flow
cytometri
lymphocyt
phenotyp
dog
use
quantifi
lymphocyt
subpopul
coupl
cytochem
method
ontogeni
therapeut
sensit
myeloprolif
disord
modiano
et
al
cyclophosphamid
cy
drug
interfer
cell
prolifer
crosslink
dna
calabresi
chabner
use
standard
challeng
substanc
immunotoxicolog
investig
burn
et
al
dean
et
al
antineoplast
therapi
dog
human
medleau
et
al
calabresi
chabner
gener
cy
known
suppress
humor
cellmedi
immun
respons
rodent
rat
model
caus
reduc
bcell
number
srbcspecif
serum
igm
level
ladic
et
al
burn
et
al
dean
et
al
preferenti
inhibit
bcell
respons
may
possibl
due
decreas
product
surfac
express
immunoglobulin
burn
et
al
dog
medleau
et
al
report
cy
reduc
leukocyt
antibodi
respons
lymphocyt
blastogenesi
affect
object
organ
system
approach
immunotoxicolog
assess
detect
advers
effect
suppress
hypersensit
endocrin
disrupt
prepubert
thymu
directli
indirectli
relat
exposur
drug
chemic
direct
toward
compon
immun
system
burn
et
al
usepatsca
purpos
studi
evalu
immunoglobulin
igm
igg
ige
elisa
lymphocyt
pant
panb
flow
cytometri
detect
advers
effect
dog
administ
posit
control
challeng
immun
system
reagent
use
elisa
consist
captur
antibodysheep
antidog
iggaffin
purifi
goat
antidog
igeaffin
purifi
goat
antidog
igm
affin
purifi
bethyl
laboratori
montgomeri
tx
standard
canin
immunoglobulin
refer
serum
bethyl
laboratori
secondari
antibodysheep
antidog
igg
horeseradish
peroxidas
hrp
goat
antidog
ige
hrp
goat
antidog
igm
hrp
conjug
bethyl
laboratori
materi
chemic
use
immulon
flatbottom
plate
dynatech
lab
burlington
block
buffer
mm
phosphatebuff
salin
ph
tween
wash
buffer
ml
tween
l
highperform
liquid
chromatographi
hplc
water
phosphatecitr
buffer
urea
hydrogen
peroxid
tablet
azinobi
acid
diammonium
abt
suppli
sigma
chemic
st
loui
mo
ubottom
micropl
flow
cytometri
perform
use
facscalibur
flow
cytomet
becton
dickinson
san
jose
ca
reagent
use
phycoerythrin
pe
antihuman
fluorescein
isothiocyan
fitc
rat
igg
fitc
rat
igg
pe
rat
igg
pharmingen
san
diego
ca
rat
anticanin
fitc
rat
anticanin
pe
rat
anticanin
fitc
serotec
raleigh
nc
dulbecco
phosphatebuff
salin
pierc
rockford
il
fetal
calf
serum
sigma
materi
includ
hplc
grade
water
ammonium
chlorid
sodium
azid
potassium
bicarbon
ethylenediamin
tetraacet
acid
edta
tetrasodium
sigma
falcon
test
tube
ml
centrifug
tube
cap
posit
control
substanc
test
biolog
specif
duramun
cvk
lci
canin
distemp
adenoviru
parainfluenza
parvoviru
leptospira
coronaviru
fort
dodg
laboratori
fort
dodg
ia
cyclophosphamid
sigma
consid
challeng
substanc
b
respect
anim
ration
fed
purina
mill
lab
canin
diet
analyz
contamin
pmi
feed
inc
st
loui
mo
immunoglobulin
dog
serum
measur
antibodi
captur
elisa
method
immunotox
serum
sampl
taken
control
anim
conduct
method
test
serum
test
sampl
taken
aliquot
store
thaw
brought
room
temperatur
analyz
prior
run
sampl
optim
concentr
antigen
coat
usual
mgml
conjug
determin
optim
dilut
standard
test
sera
also
determin
procedur
immulon
flat
bottom
plate
prepar
ad
ml
optim
concentr
captur
antibodi
mm
phosphatebuff
salin
ph
test
well
column
micropl
column
plate
use
determin
nonspecif
bind
orient
plate
column
serv
blank
addit
captur
antibodi
plate
seal
prevent
evapor
store
overnight
captur
antibodi
bind
step
follow
wash
step
use
biotek
micropl
washer
follow
set
ml
wash
buffer
fill
volum
soak
time
three
cycl
step
use
incub
procedur
test
well
block
addit
ml
mm
phosphatebuff
salin
ph
tween
h
room
temperatur
incub
plate
wash
previous
describ
ml
block
buffer
ad
well
column
next
appropri
test
sampl
standard
dilut
block
buffer
ml
ad
ubottom
plate
sampl
standard
perform
duplic
plate
addit
ml
standard
test
sera
ubottom
plate
column
immulon
plate
perform
use
multichannel
pipett
serial
dilut
prepar
column
plate
incub
h
room
temperatur
follow
wash
step
ml
secondari
antibodi
ad
test
well
incub
h
room
temperatur
prepar
citrat
buffer
one
tablet
per
ml
distil
water
perform
approxim
min
prior
use
peroxidas
substrat
prepar
ad
one
abt
tablet
everi
ml
citrat
buffer
wash
step
ml
substrat
ad
well
plate
plate
incub
standard
first
plate
reach
optim
optic
densiti
nm
biotek
cere
micropl
reader
subsequ
plate
read
use
time
read
point
data
collect
micropl
reader
enter
corel
quattro
pro
worksheet
mean
absorb
valu
calcul
dilut
standard
sampl
linear
portion
standard
curv
identifi
use
log
log
curv
fit
standard
curv
concentr
absorb
valu
convert
log
scale
calcul
regress
equat
curv
establish
absorb
valu
unknown
compar
standard
determin
gravimetr
unit
unknown
sampl
gravimetr
unit
close
togeth
averag
use
obtain
final
gravimetr
unit
log
valu
convert
base
mean
standard
deviat
coeffici
variat
obtain
gravimetr
unit
sampl
fresh
whole
blood
sampl
collect
control
anim
cephal
venipunctur
conduct
method
test
flow
cytomet
use
analyz
fitcor
peconjug
monoclon
antibodi
cell
antigen
optim
antibodi
titer
previous
determin
antibodi
dilut
work
buffer
protein
carrier
ml
fetal
calf
serum
ml
work
buffer
prepar
fresh
daili
protect
light
lyse
buffer
stock
solut
ph
prepar
dissolv
g
ammonium
chlorid
g
potassium
bicarbon
g
edtatetrasodium
ml
hplc
grade
water
work
solut
lyse
buffer
prepar
maintain
room
temperatur
work
buffer
prepar
dulbecco
phosphatebuff
salin
dpb
contain
calcium
magnesium
addit
g
sodium
azid
ml
dpb
cold
buffer
use
dilut
wash
cell
procedur
follow
ml
whole
blood
ad
ml
lyse
buffer
room
temperatur
tube
cap
mix
invers
left
stand
room
temperatur
min
mixtur
centrifug
g
min
room
temperatur
supernat
aspir
remain
content
mix
gentli
ml
cold
work
buffer
ad
mix
centrifug
g
min
supernat
aspir
pellet
resuspend
ml
work
buffer
protein
carrier
confirm
cell
viabil
may
perform
point
experi
optim
concentr
approxim
ml
lower
concentr
found
accept
singl
color
stain
ml
fitcor
pelabel
antibodi
ad
appropri
label
falcon
test
tube
ml
cell
prepar
pipet
tube
mixtur
incub
dark
ice
bath
least
min
auto
isotyp
control
analyz
sampl
incub
approxim
ml
work
buffer
ad
tube
unabl
analyz
immedi
store
dark
ice
bath
analyz
within
h
result
obtain
facscalibur
enter
spread
sheet
appropri
statist
gener
limit
number
publish
canin
valu
captur
elisa
flow
cytometri
caus
robust
set
accept
criteria
appli
prior
use
good
laboratorygood
autom
laboratori
practic
regulatori
studi
taylor
accept
criteria
elisa
includ
linear
intraassay
reproduc
system
precis
interassay
reproduc
method
precis
accuraci
observedexpect
immunolog
specif
accept
criteria
flow
cytometri
intraassay
reproduc
system
precis
biolog
specif
assay
determin
use
posit
control
challeng
substanc
target
speci
purebr
male
femal
nullipar
nonpregn
beagl
dog
cani
familiari
obtain
white
eagl
laboratori
doylestown
pa
thestudi
design
requir
eight
anim
four
male
four
femal
approxim
month
age
immun
similar
modifiedl
vaccin
week
previou
start
studi
beagl
select
test
speci
accept
nonrod
speci
choic
regulatori
test
avail
larg
histor
databas
strain
dog
import
mechanist
model
sever
autoimmun
diseas
studi
protocol
review
approv
institut
anim
care
use
committe
upon
receipt
anim
given
complet
physic
examin
veterinarian
place
individu
pen
acclim
quarantin
prior
pretreat
measur
anim
hous
accredit
facil
environ
regul
continu
monitor
maintain
room
temperatur
rang
rel
humid
rang
daili
photoperiod
approxim
h
light
h
dark
treatmentbystudi
design
brune
kintz
chosen
reduc
number
anim
need
use
anim
control
minim
intersubject
variabl
similar
statist
power
use
regulatori
studi
rational
util
organ
system
concord
approach
assess
immun
system
mean
incorpor
humor
antibodi
enumer
lymphocyt
popul
patholog
evalu
lymphoreticular
organ
aid
interpret
potenti
advers
toxicolog
respons
clinic
chemistri
urinalysi
complet
blood
count
includ
differenti
flow
cytometri
phenotyp
perform
anim
twice
prior
administr
challeng
substanc
serum
sampl
retain
measur
immunoglobulin
combin
vaccin
given
day
next
day
follow
immun
serum
sampl
taken
analysi
igg
igm
ige
along
clinic
chemistri
hematolog
urinalysi
flow
cytometri
day
evalu
possibl
influenc
repeat
immun
day
cy
administ
challeng
substanc
b
prior
dose
singl
pretreat
clinic
chemistri
urinalysi
complet
blood
count
includ
differenti
flow
cytometri
phenotyp
serum
retain
immunoglobulin
done
dog
band
tlymphocyt
subpopul
measur
pant
panb
dog
given
singl
mgkg
intraperiton
inject
cy
daili
day
day
clinic
chemistri
hematolog
urinalysi
flow
cytometri
phenotyp
retain
serum
profil
done
anim
day
statist
analysi
perform
use
number
cruncher
statist
softwar
ncss
kaysvil
ut
continu
data
analyz
mann
whitney
utest
pair
ttest
probabl
valu
p
b
accept
signific
data
visual
inspect
trend
aid
orthogon
polynomi
linear
trend
analysi
accept
criteria
result
elisa
igg
igm
ige
method
given
tabl
three
immunoglobulin
assay
accept
linear
intraassay
coeffici
variat
accept
igg
igm
ige
respect
expect
conduct
differ
day
method
precis
interassay
coeffici
variat
greater
consid
accept
tabl
accuraci
defin
percent
observedexpect
averag
igg
igm
ige
respect
immunolog
specif
canin
parallel
respect
standard
curv
rat
three
immunoglobulin
detect
limit
ngml
igg
igm
ige
respect
tabl
linear
rang
igg
ngml
igm
ngml
ige
ngml
consid
accept
base
subsequ
biolog
specif
test
day
fig
b
fig
intraassay
reproduc
measur
lymphocyt
subpopul
found
accept
tabl
percent
coeffici
variat
respect
biolog
specif
base
treatment
cy
posit
control
challeng
substanc
target
speci
fig
b
predomin
basal
immunoglobulin
pretreat
igg
mgdl
follow
igm
mgdl
lowest
basal
concentr
ige
mgdl
accord
captur
elisa
method
fig
b
fig
serum
sampl
taken
previou
day
immunolog
challeng
day
demonstr
biolog
trend
nonstatist
physiolog
relev
humor
respons
increas
igm
preced
increas
igg
sex
discern
trend
ige
respons
due
immun
fig
consist
sinc
ige
function
primarili
type
hypersensit
releas
vasoact
agent
statist
differ
day
due
multipl
vaccin
compar
pretreat
day
expect
food
consumpt
bodi
weight
affect
immun
clinic
sign
attribut
immunolog
challeng
evid
clinic
chemistri
hematolog
urinalysi
alter
discern
influenc
select
lymphocyt
paramet
attribut
immun
challeng
cyclophosphamid
treatment
day
contribut
trend
decreas
igm
preced
increas
igg
sex
possibl
influenc
normal
declin
anamnest
respons
hyperimmun
fig
b
ig
respons
occur
despit
decreas
rel
percent
rel
b
cell
total
leukocyt
count
immunoglobulin
level
appear
littl
chang
cy
treatment
day
three
immunoglobulin
decreas
dramat
nonstatist
biolog
trend
principl
flow
cytometri
find
relat
cy
rel
bcell
decreas
dramat
progress
compound
administr
statist
decreas
male
day
compar
day
fig
b
rel
contribut
increas
ratio
remain
rel
unchang
total
white
blood
cell
wbc
decreas
progress
increas
rel
male
statist
signific
accord
twosampl
ttest
day
compar
pretreat
day
rel
increas
absolut
number
dramat
decreas
expect
data
present
principl
hematolog
find
note
rel
segment
neutrophil
increas
rel
lymphocyt
decreas
day
cy
suggest
stress
leukogram
howev
begin
day
cy
rel
segment
neutrophil
markedli
decreas
rel
lymphocyt
increas
along
reduc
ratio
suggest
granulopoiet
hypoplasia
rel
monocyt
eosinophil
decreas
progress
evid
moder
nonregen
anemia
mark
thrombocytopenia
principl
gross
patholog
observ
consid
due
cy
treatment
includ
inflamm
urogenit
tract
gray
discolor
tonsil
thymic
atrophi
principl
micropatholog
find
consist
lymphoid
deplet
lymph
node
mesenter
retropharyng
thymu
spleen
tonsil
along
erythrophagocytosi
lymph
node
addit
diffus
mark
hypocellular
sternal
bone
marrow
anim
food
consumpt
bodi
weight
dramat
reduc
clinic
sign
observ
attribut
cy
treatment
includ
abdomin
ascit
darkmucoid
fece
decreas
activ
red
peni
male
vagin
open
femal
hematuria
hematochezia
vomit
dehydr
thin
bodi
condit
addit
system
effect
cy
includ
decreas
tsh
increas
alp
bile
acid
along
proteinuria
hematuria
day
initi
cy
challeng
dog
repres
anim
welfar
challeng
regard
number
subject
use
regulatori
studi
well
scientif
challeng
common
nonrod
speci
extrapol
man
risk
assess
therefor
studi
design
approach
scientif
clinic
valid
limit
regulatori
studi
evalu
immun
system
base
concord
holist
keil
et
al
assess
humor
antibodi
respons
enumer
lymphocyt
popul
function
lymphoreticular
organ
burn
et
al
elisa
flow
cytometri
assess
met
current
industri
object
tier
ii
immunolog
test
design
rodent
dean
et
al
pallardi
et
al
howev
applic
method
toxicolog
test
dog
studi
conduct
good
laboratori
practic
minim
elisa
method
chosen
advantag
enhanc
immunolog
sensit
accuraci
compar
exist
rid
method
tizard
nonspecif
immunoglobulin
chang
success
use
human
occup
medicin
detect
possibl
immunotox
potenti
antigen
exposur
pesticid
mixtur
pollut
inject
expos
directli
test
subject
interest
stillerwinkl
et
al
studi
found
multipl
vaccin
administ
nonadvers
humor
antibodi
respons
detect
gener
immunoglobulin
respons
pattern
due
administr
vaccin
challeng
typic
initi
igm
respons
preced
igg
upon
subsequ
challeng
enhanc
anamnest
respons
immunoglobulin
observ
tizard
immunoglobulin
e
normal
dog
found
extrem
low
concentr
major
import
type
hypersensit
reaction
atopi
parast
hammerberg
et
al
ginel
et
al
coeffici
variat
largest
igg
similar
magnitud
previous
report
german
et
al
vaccin
challeng
demonstr
normal
function
respons
increas
igg
igm
lack
ige
respons
translat
advers
toxicolog
respons
neither
immun
cy
challeng
reveal
clear
immunoglobulin
respons
differ
attribut
sex
anim
small
studi
howev
given
thymu
involut
pubert
influenc
occur
dog
use
regulatori
test
age
rang
month
seem
appropri
account
variat
age
sex
measur
immunoglobulin
report
ige
racin
et
al
igg
igm
iga
schreiber
et
al
german
et
al
declin
igm
igg
cy
test
may
reflect
halflif
circul
immunoglobulin
consid
approxim
day
burn
et
al
addit
immunoglobulin
level
cy
challeng
may
influenc
secondari
system
effect
protein
homeostasi
albumin
concentr
known
correl
igg
german
et
al
previou
work
cy
dog
singl
dose
mgkg
intraven
found
decreas
lymphocyt
number
effect
antibodi
respons
lymphocyt
blastogenesi
medleau
et
al
flow
cytometri
becom
critic
cell
biolog
tool
quantifi
sort
specif
phenotyp
character
structur
function
attribut
meet
increas
demand
mechanist
work
regulatori
studi
gossett
et
al
use
flow
cytometri
demonstr
rel
bcell
decreas
attribut
cy
treatment
increas
contribut
consid
dramat
decreas
total
wbc
unchang
ratio
indic
absolut
valu
dramat
decreas
preferenti
inhibit
bcell
respons
may
possibl
due
decreas
product
surfac
express
immunoglobulin
burn
et
al
advers
reaction
human
associ
clinic
use
cyclophosphamid
includ
vomit
anorexia
hemorrhag
coliti
leukopenia
hemorrhag
ureter
cystiti
calabresi
chabner
observ
clinic
necropsi
studi
previous
demonstr
neurolog
ophthalmolog
investig
appropri
conduct
within
framework
exist
guidelin
studi
nest
hypothesi
benefit
batteri
test
organ
system
assess
drug
chemic
toxicodynam
profil
jone
et
al
multivari
statist
analysi
data
gather
assess
immun
system
whole
describ
keil
et
al
would
seem
use
tool
toward
attempt
character
complex
immunotox
conclud
concord
approach
assess
immun
system
incorpor
humor
antibodi
enumer
lymphocyt
popul
patholog
evalu
lymphoreticular
organ
assist
interpret
advers
toxicolog
respons
elisa
method
measur
ig
detect
nonspecif
biolog
respons
follow
immun
cy
treatment
flow
cytometri
method
detect
advers
chang
lymphocyt
subpopul
cy
treatment
method
accept
may
ad
screen
batteri
need
assess
tier
ii
immunotox
within
framework
exist
guidelin
chronic
nonrod
regulatori
studi
